Idera Pharmaceuticals Inc (IDRA) stock is higher by 147.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives IDRA stock a score of 90 out of a possible 100.
That rank is influenced by a long-term technical score of 98. IDRA's rank also includes a fundamental score of 88. In addition to the average rating from Wall Street analysts, IDRA stock has a mean target price of 7.5. This means analysts expect the stock to increase 64.47% over the next 12 months. The short-term technical score for IDRA is 83.
What's Happening with IDRA Stock Today
Idera Pharmaceuticals Inc (IDRA) stock is higher by 26.91% while the S&P 500 has fallen -0.19% as of 11:37 AM on Friday, Nov 20. IDRA is higher by $0.97 from the previous closing price of $3.59 on volume of 989,996 shares. Over the past year the S&P 500 is higher by 15.19% while IDRA is higher by 147.83%. IDRA lost -$2.80 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Idera Pharmaceuticals Inc (IDRA) Stock.
